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Abstract
Background: Lumbar spinal stenosis (LSS) and peripheral arterial disease (PAD) are two distinct conditions
characterized by similar symptoms including leg pain and walking limitations due to claudication. Differentiation
between both origins can be difficult and characteristics such as symptom manifestations, time to relief in rest
position and pain localization should be considered when determining diagnosis and the treatment plan. The
objectives of this study were to compare changes in walking time to symptom change during treadmill tests and
self-reported outcomes measures related to claudication, kinesophobia and global health between individuals with
LSS, PAD and non-specific low back pain (nLBP).
Method: Fifty-five patients (23 with LSS, 14 with PAD and 18 with nLBP) were recruited from May 2018 to March
2020 to complete a treadmill walking test involving two 5-min walking tasks (Upright and Forward Leaning Trunk
(FLT) Walking tasks). The speed was set at 1.9 km/h (1.2 mph), and each task was followed by a 5-min rest period.
Walking time to symptom change and Total walking time were recorded during each walking task. Patients were
asked to complete four questionnaires related to the impact of claudication, walking impairment, kinesiophobia and
global health. One-way ANOVAs were performed to compare walking time difference from the Upright to the FLT
walking tasks and to compare questionnaires results between groups.
Results: One-way ANOVAs showed a significant difference between groups regarding difference in Walking time to
symptom change between both tasks (F = 4.12, p = 0.022). The LSS group improved its Walking time to symptom
change from the Upright to the FLT walking tasks more than the PAD (p = 0.34) and the nLBP group (p = 0.12). The
nLBP group was less impacted by claudication and less impaired during walking compared to the LSS and PAD
groups (ps < 0.001). The nLBP group also had less kinesiophobia than the LSS one (p < 0.001), but was similar to the
PAD group. The global health rating was not statistically different between groups (p = 0.118).
Conclusion: The test was able to distinguish neurogenic from vascular or nLBP related claudication. However,
further studies are needed to validate this new treadmill walking test.
Trial registration: clinicaltrials.gov (NCT04058171), Registered August 15, 2019 –Registered during recruitment
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Background
Intermittent claudication (IC) is defined as lameness due
to leg pain while standing or walking [1], with the leg
pain attenuating within seconds to a few minutes when
stopping activity or sitting [2–4], based on the under-
lying health condition. Vascular and neurogenic claudi-
cation represent both possible origins of IC, and their
symptoms are frequently described as pain, cramps,
numbness and tingling in the lower limbs [5]. Vascular
claudication is a common manifestation in individuals
with peripheral arterial disease (PAD), while neurogenic
claudication occurs in lumbar musculoskeletal disorders
with neurological involvement such as specific low back
pain (LBP) conditions. One of these specific LBP condi-
tions causing neurogenic claudication is lumbar spinal
stenosis (LSS). In some cases, individuals with non-
specific low back pain (nLBP) will experience referred
pain into the lower limbs which will also cause difficulty
during walking [6].
Peripheral arterial disease is a condition affecting the
blood vessels caused by a narrowing of the arteries, usu-
ally brought on by the accumulation of atheroma plates
(atherosclerosis) [1]. This accumulation leads to insuffi-
cient blood supply to the muscles which is accentuated
with increasing intensity of activities such as walking [7].
Vascular claudication is the most common manifestation
of PAD [8] and its prevalence is estimated at 10 to 20%
[9] in 40-year-old individuals, whereas this number dou-
bles in individuals older than 60 years of age [10]. When
PAD patients are walking the need in oxygen increases
in muscles and the insufficient blood supply leads to
pain into the leg(s) and subsequently to the need to stop
or to sit to relieve the pain.
Lumbar spinal stenosis is a condition leading to mech-
anical compression or ischemia of the nerve roots caus-
ing neurogenic claudication [1, 11]. LSS is a
degenerative musculoskeletal condition affecting up to
20% of the global population [12] with an increase in the
incidence with advancing age [13], and it affects mainly
individuals 65 years and older [14]. The acquired central
LSS form arises from the degenerative process of the
lumbar spine. Different osteoarthritic manifestations in-
cluding ligamentous hypertrophy (ligamentum flavum),
disc degeneration (bulging or hernia), spondylolisthesis
and/or facet osteoarthritis [3, 15, 16], may result in de-
creased space in the vertebral canal, leading to central
LSS. In LSS, leg pain occurs while walking or standing
for a moment and is relieved in seated position or by
flexing the trunk forward [17].
Non-specific low back pain is a musculoskeletal condi-
tion defined as pain located between the 12th ribs and
the gluteal fold [18, 19], with or without referred pain in
one or both lower limbs [20]. For patients with nLBP,
pain in the lower limb is commonly due to referred pain
into the buttock or thigh (above the knee) and there is
no neurological impairment [6]. Low back pain is a very
common symptom experienced by individuals of any age
and particularly in people between 40 and 80 years old
[18, 20], with a lifetime prevalence of 84% [21]. The term
nLBP describes LBP for which a specific cause of pain
cannot be identified [20]. Among people with nLBP,
some of the most common sources of referred pain into
the lower limbs are sacroiliac joint syndrome, discogenic
low back pain and facet joint pain [22]. In acute, sub-
acute or chronic nLBP with referred pain into one or
both legs, patients can have difficulty with activities such
as dressing, standing and walking [23].
Even if these three conditions have distinct mecha-
nisms, they can all affect walking capacity of patients
through one of their main symptoms: intermittent clau-
dication. Vascular and neurogenic claudication share
similarities in their symptoms [2], but the posture of re-
lief differs between both types. In fact, in PAD, patients
need to stop their activity while in LSS, patients need to
adopt a bending forward posture or to sit down. Add-
itionally, both claudication origins lead to several limita-
tions in daily physical activities, such as a reduction of
walking time and walking distance [2, 17, 24, 25]. Be-
cause of their similarities, clinicians must establish their
diagnosis based on the reported symptoms and clinical
manifestations in daily activities and combine the clinical
history with diagnostic tests or medical imaging. Now-
adays, the diagnosis of PAD is obtained using the stand-
ard Ankle-Brachial Index (ABI) [25, 26] which assess the
systolic blood pressure ratio between the ankle and the
brachial artery (ratio lower than 0.9 is defined as a sign
of PAD) [27], while the diagnosis of LSS is commonly
determined using magnetic resonance imaging (MRI),
even if MRI is a diagnostic tool that presents important
limitations [28]. In fact, Boden showed that 21% of
asymptomatic individuals over 60 years had lumbar
spinal stenosis on MRI [29].
Clinicians are currently facing an important challenge
in the assessment and the diagnosis of the intermittent
claudication origin because access to health care re-
sources can be difficult. For example, the mean time be-
tween the referral by a general practitioner to the
consultation with a neurosurgeon was about 32.9 weeks
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in Canada in 2017 [30]. For patients with claudication,
timely and accurate diagnosis are important aspects to
consider as they directly influence the patient trajectory
and clinical outcome. Knowing that trunk flexion, well
known as the shopping cart sign, represents the hall-
mark in LSS claudication, the use of this specific clinical
characteristic may be useful to rapidly distinguish be-
tween vascular and neurogenic claudication. Indeed,
people with vascular claudication or nLBP should not be
responsive to the modification of the trunk position
while walking compared to LSS. Using clinical manifes-
tations, such as the relief of leg pain with the bending
forward position, that are specific to neurogenic claudi-
cation could be an additional resource to help clinicians
to rapidly distinguish between vascular and neurogenic
claudication which would also improve directing patients
to the most appropriate specialist.
Therefore, the first objective of this study was to com-
pare changes in Walking time to symptom change be-
tween groups of individuals with LSS, PAD and nLBP.
The second objective was to compare self-reported out-
come measures such as the impact of claudication, walk-
ing impairment, kinesiophobia and global health
between groups. We hypothesized that participants in
the LSS group would increase their Walking time to
symptom change and their total walking time by bend-
ing their trunk forward while walking compared to both
the PAD and nLBP groups. We also hypothesized that
participants in the nLBP group would report lower im-
pact of claudication, walking impairment and kinesio-
phobia and that they would have higher global health
score than the LSS and the PAD group.
Methods
This crossover study was completed at the Motor con-
trol and neuromechanics laboratory at the Université du
Québec à Trois-Rivières (Canada). Recruitment and test-
ing of participants were conducted from May 2018 to
March 2020.
Participants
Participants were recruited in collaboration with the
Centre Intégré Universitaire de Santé et de Service
Sociaux de la Mauricie et du Centre-du-Québec
(CIUSSSMCQ) neurosurgeons, vascular surgeons and
family doctors, as well as with clinicians from the UQTR
university chiropractic outpatient clinic. To be included
in the study, participants had to have a main diagnosis
of degenerative LSS or PAD with intermittent claudica-
tion, or of nLBP with referred pain in the lower limbs,
and respect inclusion and exclusion criteria presented in
Table 1. The main focus of the study was to compare
participants with claudication from central lumbar spinal
stenosis and peripheral artery disease. Therefore, pa-
tients with foraminal lumbar spinal stenosis were ex-
cluded from this first stage of treadmill walking test
development. Participants were enrolled and classified
into one of the three study groups based on the referring
clinicians (neurosurgeons, vascular surgeons, family phy-
sicians or chiropractors) diagnosis and evaluation. The
nLBP group acted as a control group in this study.
This study was approved by the CIUSSSMCQ research
ethics committee (CER-2017-017) and by the Université
du Québec à Trois-Rivières ethics committee for re-
search with human beings (CER-18-244-10.01). All pa-
tients provided informed written consent prior to their
participation in the study. The study was registered at
clinicaltrials.gov (NCT04058171).
Demographics data
Data collection began with a brief history to gather
demographic data as well as information regarding diag-
nosis, number of years with claudication, time of diagno-
sis, presence of comorbidities and perceived symptoms
(for example cramp, numbness, tingling and twinges).
Mean and maximum leg pain intensity over the past
week and at the time of testing were assessed using a 10
cm visual analog scale (VAS). All clinical and physical
outcomes were assessed during a single one-hour
session.
Table 1 Inclusion and exclusion criteria
Lumbar spinal stenosis Peripheral arterial disease Non-specific low back pain
Inclusion criteria - Central canal stenosis
- Pain in at least one leg
- Neurological signs in the lower limbs (numbness or tingling)
- Perceived weaknesses in the lower limb
- Pain relieved by sitting or bending the trunk
- > 50 years old
- Confirmed imaging of LSS
- Claudication while walking
- Ankle-brachial index < 0.9
- Pain relieved by rest
- > 50 years old
- Referred pain in the lower limb(s)
- Pain relieved by sitting
- > 40 years old
Exclusion criteria - Foraminal stenosis - Type 1 diabetes
- Spinal stenosis with predominant back pain - Knee or hip osteoarthritis
- Symptomatic disc herniation with nerve root irritation - Hip or knee arthroplasty
- Previous lumbar surgery - Inability to provide free and informed consent
- Previous vascular surgery
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Clinical outcomes - questionnaires
Four questionnaires were used to describe the impact of
the claudication, walking impairment, kinesiophobia and
perceived global health of participants in each group.
The first questionnaire was the validated French-
Canadian adaptation of the Swiss Spinal Stenosis Ques-
tionnaire (FR-SSSQ) [31]. This questionnaire is an LSS-
specific tool used to assess pain, function and satisfac-
tion with care commonly used in spinal stenosis pa-
tients. In this study, the part assessing satisfaction of
care in patients was removed because no patient had
undergone surgery. The pain subscale includes seven
questions which six are scored using a five-point Likert
scale and the seventh question is scored using 1, 3 or 5
points. The function subscale includes five questions
which are scored using a four-point Likert scale. For
each subscale, a higher score indicates greater disability.
The total score of the FR-SSSQ without the satisfaction
subscale was then 55.
The second questionnaire, the French version of
Walking Impairment Questionnaire (WIQ) evaluated
patient-perceived walking performance. This validated
questionnaire provides estimates of walking distance,
walking speed and stair-climbing capacity [32, 33]. Two
of the three WIQ components are scored using a four-
point Likert scale. For walking distance score, zero rep-
resents the inability to walk the distance and four repre-
sents the ability to walk the distance without difficulty.
For the walking speed, 0 represents the inability to walk
at the suggested speed and 4 represents the ability to jog
or run [32]. The third component, ability to climb stairs,
is measured using a three-point Likert scale. The total
WIQ score ranges from 0 to 100 (transformation of each
subscale was completed using the mathematical formula
of the questionnaire).
Kinesiophobia was also assessed using the French-
Canadian version of the Tampa Scale of Kinesiophobia
(TSK) [34], a 17-item questionnaire evaluating fear of
movement, with higher scores reflecting an increased
level of kinesiophobia [35]. Each TSK question is quanti-
fied using a 4-point Likert scale (1 = strongly disagree
and 4 = strongly agree) with a total maximum score of
68 points. Finally, to evaluate the patients’ own global
assessment of health, the 0–100 visual analog scale
(VAS) of the EuroQol French version (EQ-5D) was used
[36, 37].
Physical outcomes - treadmill walking test
Patients were invited to complete two different walking
tasks on a treadmill (the Upright walking task and the
Forward Leaning Trunk (FLT) walking task) at a con-
stant speed of 1.9 km/h (1.2 mph) with zero degree of
inclination [38]. The walking speed was established to
allow participants to walk comfortably, but if it was
deemed inadequate for participants, they could walk at a
lower preferred walking speed. A handrail was added to
the treadmill, and it was at the disposal of participants
during both walking tasks. However, the handrail height
was adjusted to each participant during the Forward
trunk lean walking task with the objective to mimic a
shopping cart (see Fig. 1) and to ensure that they would
keep the trunk forward lean position while being com-
fortable and secure. In both walking tasks, participants
were allowed to use the handrail, but they were asked
not to grip it with their hands. Each walking task was
performed for a maximum of 5 min, because symptoms
in both claudication types should occur or increase rap-
idly when walking and because of the time constraint in
clinics.
Upright Walking Task
During this walking task, participants were asked to walk
on the treadmill with an upright trunk position.
FLT Walking Task
During this task, participants were asked to walk on the
treadmill with a trunk flexion position. First, the ana-
tomical position of each participant was used as the
starting point and considered as 0° of trunk flexion.
Then participants put their hands on the handrail with-
out putting weight on it and the digital inclinometer (±
0.1° of precision, model 40–6067, Johnson Level & Tool
Mfg. Co., Inc. Mequon, WI) was placed on the spinous
process of L3. Finally, the patients were asked to bend
forward until 20° of flexion was reached. The FLT pos-
ition was monitored every 30 s during the task and cor-
rected when needed.
Each walking task was followed by a five-minute
seated rest period to allow symptoms to alleviate or sub-
side (i.e., return to their initial intensity according to
participants symptoms before the walking task). Back
and leg pain intensity was assessed halfway (2:30 min)
and at the end of the rest period (5 min). The two walk-
ing tasks were randomized within each group using a
computer-generated sequence. Prior to the beginning of
each walking task, patients were instructed to indicate
the onset or the increase of their symptoms (Walking
time to symptom change) and at least one reminder was
made during the tasks. The total duration of each walk-
ing task was defined by either reaching 5 min or by the
incapacity to continue the test because of leg symptoms,
according to what occurred first.
Statistical analysis
Statistical analyses were performed using SPSS statistical
version 26 for Windows software, and the level of sig-
nificance was set at p < .05. The Kolmogorov–Smirnov
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test was used to assess each variable for normal
distribution.
Demographic data and clinical outcomes
Pearson Chi-Square test was performed to compare gen-
der proportion between groups. One-way analyses of
variance (ANOVAs) were conducted to assess if groups
were similar for age, height, and weight. One-way ANO-
VAs were also conducted to compare the impact of clau-
dication, walking impairment, kinesiophobia and quality
of life between groups. Post hoc analyses were con-
ducted using Tukey’s post hoc test for pairwise compari-
sons whenever necessary.
Treadmill walking test
The Pearson Chi-square was used to compare the pro-
portion of participants in each group who increased
their walking time between the Upright to the FLT walk-
ing tasks for both Walking time to symptom change and
Total walking time. Then, T-test were performed to ver-
ify if there was not an order effect between walking
tasks. The order effect was first verified among all partic-
ipants and it was then verified in all groups separately.
We compared Δwalking time to symptom change be-
tween participants that began with the Upright walking
task and participants that began with the FLT walking
task.
The homoscedasticity of Walking time to symptom
change was evaluated using the Levene test. One-way
ANOVA was performed to compare Walking time to
symptom change difference between groups (Δwalking
time to symptom change =Walking time to symptom
change during the FLT walking task – Walking time to
symptom change during the Upright walking task). Be-
cause of the non-parametric distribution of the data re-
garding Total walking time in each group, Kruskal-
Wallis test was conducted to assess Total walking time
difference between groups (Δtotal walking time = Total
walking time during the FLT walking task – Total walk-
ing time during the Upright walking task).
Exploratory statistics
Preliminary statistics using receiver operating character-
istic curves (ROC) were used to assess the potential per-
formance of the walking test to distinguish conditions
using Walking time to symptom change. The difference
in Walking time to symptom change between the FLT
walking task and the Upright walking task was used in
the ROC analyses to determine the sensibility and the
specificity of this new treadmill walking test.
Results
The sample size calculation indicated that in order to
achieve a statistical power of 0.80 using an alpha value
of 0.05 and a 30% between-group difference in Δwalking
time to symptom change, groups of 24 participants were
needed. However, due to the global COVID-19 pan-
demic, this study had to be interrupted. Fifty-five partici-
pants (23 with LSS, 18 with nLBP and 14 with PAD) had
been enrolled at the time recruitment was halted for an
indefinite period.
Demographic data and clinical outcomes
Demographic data and baseline clinical characteristics
are presented in Table 2. For the gender proportion ana-
lysis, Pearson Chi-square results showed that gender
proportions were similar between groups (χ2 = 1.59, p =
0.45). The one-way ANOVA showed a significant
between-group difference for age (p < 0.001) and the
Tukey post hoc analysis showed that patients were youn-
ger in the nLBP group compared to the LSS (p < 0.001)
and PAD groups (p < 0.001). However, patients were
similar regarding weight, height, body mass index (BMI)
and leg pain intensity in the previous week.
The ANOVAs for the other clinical outcomes showed
significant between-group differences. Tukey post hoc
tests revealed that patients in the LSS and PAD groups
were similar for every clinical outcome and that they
were both significantly different compared to the nLBP
group, except for kinesiophobia scores. Detailed results
are presented in Table 2. Regarding results from the
Fig. 1 Position of participants during (a) the Upright walking posture task and (b) the FLT walking task
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WIQ questionnaire, the Tukey post hoc showed that pa-
tients in the nLBP group were able to walk for a longer
period, were able to walk faster and had less impairment
during stairs climbing than the LSS and the PAD groups.
Regarding pain and functional assessments (FC-SSSQ),
the ANOVA showed significant between-group differ-
ences for pain, function and total score. FC-SSSQ scores
for pain and function subscales were significantly lower
in the previous month for the nLBP group than for the
LSS and PAD groups. For the total score of the FC-
SSSQ, the analysis revealed a significant difference be-
tween the nLBP group and the LSS group, as well as be-
tween the nLBP group and the PAD group. In each case,
the nLBP group showed a lower total score. Regarding
kinesiophobia, the Tukey post hoc showed a significant
difference between the nLBP group and the LSS group,
indicating that the nLBP group had less kinesiophobia.
The Tukey post hoc also showed a difference between
the LSS and the PAD group (p = 0.045). There was no
significant difference between the nLPB and the PAD
groups. As for the visual analog scale (VAS) section of
the EQ-5D questionnaire, results for global self-reported
health status showed that all groups were similar (p =
0.118).
Treadmill walking test
Regarding Walking time to symptom change, 87% of pa-
tients in the LSS group reported symptoms in the
Upright walking task and 83% reported symptoms in the
FLT walking task. Regarding vascular claudication, 79%
of patients in the PAD group reported symptoms during
the Upright walking task and 86% during the Forward
trunk lean walking task. Patients in the nLBP group
showed little variability for both treadmill walking condi-
tions. In fact, this group did not respond to the treadmill
walking test, as 28% of the patients reported symptoms
during the Upright walking task and 33% during the FLT
walking task. The Pearson Chi-square showed a
between-group significant difference for the Walking
time to symptom change increased (sec) between the Up-
right walking task and the FLT walking task (x2 = 7.88;
p = 0.02). This difference between group is mainly due to
the nLBP which had much lower chance of responding
to the walking tasks.
Regarding Total walking time, even if Walking time to
symptom change was sometimes brief (minimum = 19 s),
several patients were able to complete the 5-min of
walking in both tasks in the LSS group. In fact, 61% of
patients in the LSS group, compared to 50% in the PAD
group were able to walk the entire 5 min during both
the Upright walking task and the FLT walking task. Re-
garding the nLBP group, 94% of patients were able to
complete both the Upright walking task and the FLT
walking task (see Fig. 2). Kruskal-Wallis results also
showed no significant difference between groups regard-
ing Δtotal walking time (p = 0.298).








F:M 9:14 5:9 10:8 N/A
Age (years) 70.00 ± 7.66 72.43 ± 9.41 52.00 ± 9.29 < 0.001*†
Weight (kg) 82.02 ± 14.76 83.20 ± 22.15 82.26 ± 9.95 0.975
Height (m) 1.68 ± 0.09 1.89 ± 0.80 1.69 ± 0.07 0.265
BMI (kg/m2) 29.02 ± 4.05 27.65 ± 9.02 28.85 ± 3.51 0.756
Leg pain intensity in the past week (/10) 5.63 ± 2.19 6.04 ± 2.06 3.74 ± 2.33 0.008*†
WIQdistance (%) 34.91 ± 30.30 24.34 ± 31.62 89.54 ± 17.97 0.001
*†
WIQspeed (%) 31.00 ± 20.49 23.99 ± 24.33 75.24 ± 20.67 < 0.001
* †
WIQstairs (%) 20.92 ± 14.51 15.19 ± 15.82 41.88 ± 10.66 < 0.001
* †
WIQmean (%) 28.94 ± 20.52 21.17 ± 22.87 68.89 ± 14.20 < 0.001
* †
FC-SSSQpain (/35) 20.87 ± 4.25 21.86 ± 3.46 14.17 ± 4.00 < 0.001
* †
FC-SSSQfunction (/20) 11.96 ± 2.85 12.00 ± 4.22 7.39 ± 2.89 0.001
* †
FC-SSSQtotal (/55) 33.26 ± 6.29 33.86 ± 6.01 21.56 ± 5.38 < 0.001
* †
TSK (/68) 45.43 ± 8.39 38.46 ± 8.13 34.39 ± 7.91 < 0.001*#
EQ-VAS score (/100) 73.00 ± 18.38 66.79 ± 18.18 78.44 ± 6.78 0.118
* p < 0.001 between the LSS group and the nLBP group
† p < 0.001 between the PAD group and the nLBP group
# p < 0.05 between the LSS group and the PAD group
LSS: Lumbar Spinal Stenosis, PAD: Peripheral Arterial Disease, nLBP: non-specific Low Back Pain, F: female, M: male, BMI: Body Mass Index, WIQ: Walking
Impairment Questionnaire, FC-SSSQ: French-Canadian Swiss Spinal Stenosis Questionnaire, TSK: Tampa Scale of Kinesiophobia, EQ-VAS score: EQ-5D: European
Questionnaire– 5 dimensions Visual Analog Scale
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Results from the T-test showed no significative order
effect when considering all participants (p = 0.14), and
within each group (for the LSS group p = 0.40, for the
PAD group p = 0.17 and for the nLBP group p = 0.26).
One-way ANOVA showed that there was a signifi-
cant difference between groups regarding Δwalking
time to symptom change (F = 4.12, p = 0.022). Post
hoc analysis showed that participants from the LSS
group increased their walking time to symptom
change from the Upright position to the Forward lean
trunk position compared to the PAD group (p =
0.034) and the nLBP group (p = 0.012). Post hoc
analysis also showed a significant difference between
the PAD group and the nLBP group (see Fig. 3).
Considering that the mean duration for Δwalking
time to symptom change was 40.43 s and that the
mean duration for Walking time to symptom change
during the Upright walking task was 118 s, partici-
pants increased their walking time to symptom
change of 34.26%.
Exploratory statistics
The preliminary results of ROC curve analysis consider-
ing Walking time to symptom change for LSS and PAD
Fig. 2 Median, maximum and minimum for Total walking time
Fig. 3 Comparison of Δwalking time to symptom change between the three groups. LSS = lumbar spinal stenosis, PAD = peripheral arterial
disease, nLBP = non-specific low back pain
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groups showed a sensitivity of 60.9% and a specificity of
78.6% while sensitivity and specificity considering Walk-
ing time to symptom change for LSS and nLBP were re-
spectively 60.9 and 88.9%.
Discussion
The objectives of the present study were (1) to compare
changes in walking time to symptom change and (2) to
compare self-reported outcome measures such as the
impact of claudication, walking impairment, kinesiopho-
bia and global health between groups of individuals with
LSS, PAD and nLBP. As hypothesized, patients with
spinal stenosis were able to walk longer in the forward
trunk lean walking task than in the Upright walking task
before the symptom change appeared, while no differ-
ence between positions was observed for patients with
PAD and with nLBP. Our second hypothesis was also
confirmed as participants in the nLBP group reported
lower claudication impact and walking impairment than
the two other groups.
Treadmill walking test
Results from the treadmill walking test used in this study
showed that the FLT walking posture increases the
Walking time to leg symptom change compared to the
Upright walking posture for patients with LSS. This find-
ing was coherent with previous studies showing that leg
pain is decreased when patients with LSS bend their
trunk forward while walking [39, 40]. Even if claudica-
tion impact was similar for the LSS and the PAD groups,
patients in the PAD group did not increase their Walk-
ing time to symptom change from the Upright to the FLT
walking task as much as patients in the LSS group. How-
ever, Total walking time was the same for both LSS and
PAD groups. The fact that trunk position impacts Walk-
ing time to symptom changed in the LSS group as op-
posed to the PAD group suggests that it was a specific
characteristic of LSS patients. As initially hypothesized,
such differences between the two walking tasks were not
observed in patients with PAD or nLBP because of the
different mechanisms that generate claudication. Claudi-
cation in LSS is normally caused by pain due to nerve
root compression, which is accentuated with upright
posture, while claudication in PAD is caused by a nar-
rowing of the arteries; symptoms therefore increase with
the increasing oxygen demand from lower limb muscles.
For patients with nLBP, referred pain to the lower limbs
is not caused by nerve root compression or oxygen de-
mand. Referred pain to the lower limbs will be present
regardless of the trunk position. For patients with LSS,
the leaned forward posture is well known to decrease leg
symptoms [3, 14]. In fact, patients in LSS see their legs
symptoms decrease in a seated position or by the trunk
leaned forward position, which causes the vertebral canal
diameter and dural sac cross-sectional area to increase
[41]. On the contrary, and as expected, the inclined
walking posture had no positive effect on Walking time
to symptom change in patients with PAD and nLBP. Leg
symptoms in PAD are caused by the partial occlusion of
the blood vessels, which causes a decrease in oxygen
supply to muscles, and time to leg symptom change can
be influenced by the intensity of the task, which will
generate higher needs in oxygen rather than the position
of the trunk while walking [10]. During the treadmill
walking test, walking intensity was the same for both
walking tasks, which means that there was no expected
change in Walking time to symptom change and Total
walking time for patients with PAD. The nLBP group
was included in this study to highlight the differences in
leg pain arising from nLBP and LSS.
The preliminary sensitivity and specificity analysis sug-
gests that the treadmill walking test can be a helpful tool
for health care professionals who wish to assess the ori-
gin of claudication and differentiate LSS from nLBP. In
fact, the treadmill test has shown to be moderately sensi-
tive (60.9%) and moderately to highly specific (78.6–
88.9%) to the neurogenic claudication present in lumbar
spinal stenosis. In addition, the increased walking time
to symptom change observed in the LSS group was
higher than the minimally clinically important difference
(MCID) reported in a previous study [42].
Clinical outcomes
With regard to patients’ characteristics, results showed
that LSS and PAD groups were similar for a majority of
clinical outcomes. Overall, patients in both groups
showed similar mean scores for leg pain intensity in the
previous week, important walking impairment and mod-
erate pain and function impact on their daily activities.
For their part, patients with nLBP presented significant
differences from LSS and PAD patients for several char-
acteristics such as kinesiophobia and walking impair-
ment, as assessed with the WIQ and FC-SSSQ
questionnaires. In the present study, the kinesiophobia
scores were different for the LSS and PAD groups, which
is consistent with the results reported in a previous
study that compared different characteristics, including
kinesiophobia, between three groups (neurogenic claudi-
cation, vascular claudication and asymptomatic) [43]. In
fact, in the study by Woods et al. (2012), patients with
neurogenic claudication had a higher score on the
Tampa Scale of Kinesiophobia Questionnaire than pa-
tients with vascular claudication. Regarding quality of
life, the present study suggests that patients with neuro-
genic or vascular claudication still consider having a
good health status, according to their rating of health on
the EQ-5D VAS scale. In addition, according to the
WIQ and FC-SSSQ questionnaires, patients from the
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current study with LSS or PAD were impacted by claudi-
cation; this impact was also observable during the tread-
mill walking test, as only 55% of patients with LSS and
50% of patients with PAD were able to walk for the en-
tire 5 min. As the results regarding self-reported mea-
sures were similar between LSS and PAD, the treadmill
walking test was able to distinguish between these two
distinct conditions.
Limitations
The study is not without limitations, since we assumed
that diagnosis was unequivocal to a neurosurgeon and/
or a vascular surgeon regarding patients with LSS or
PAD and to a chiropractor regarding patients with
nLBP. We did not have access to medical files nor to the
clinical test results done by the neurosurgeon and/or the
vascular surgeon, which means that some patients could
have originally been incorrectly classified or have had
coexisting vascular and neurogenic claudication. The co-
existence of both claudication types in one patient may
have limited the treadmill walking test discriminating
performance. In fact, clinicians should not assume that a
negative treadmill test definitively rules out LSS. In
addition, due to the modest sample size, results should
be interpreted with caution. In fact, results may be over-
estimated due to the low variability between the patients
of the three groups concerning their walking capacity
and the severity of their pathology. The fixed speed walk
was another limitation, as it sometimes made patients
uncomfortable during the walking tasks. Another limita-
tion of this study was that the reliability of the treadmill
walking test was not measured. For future studies, self-
pace walking task should be considered to assess leg
symptoms, since it may better represent the daily life ac-
tivities of patients.
Clinical implications
Interestingly, 95% of participants were able to complete
the treadmill test at the predefined walking speed. In
addition, all patients were back to their baseline leg pain
intensity within the 5-min rest period that followed both
treadmill walking tasks. This study showed that a short
treadmill walking test can help health care professionals
to discriminate the neurogenic claudication from the
vascular claudication. The next stages of the treadmill
test development should include patients with other spe-
cific LBP that are associated with leg pain. To our know-
ledge, this is the first treadmill walking test to assess the
difference between neurogenic and vascular claudication
in a quantitative way. The approach, when fully vali-
dated, could contribute to the early detection of claudi-
cation origin and consequently improve care pathways.
This early identification should contribute to speeding
up the establishment of a treatment plan and allow early
referral to the best health care specialist based on the
origin of the claudication.
Conclusion
Preliminary results for this new treadmill walking test
showed that patients with LSS increase their walking
time to symptom change compared to PAD and nLBP
groups when walking with a leaned forward trunk pos-
ition. Exploratory results also showed that the test was
moderately sensitive and moderately to highly specific to
symptoms manifestations of claudication in LSS. This
treadmill walking test seems to be an interesting tool to
help health care workers distinguish the origin of the
claudication and establish a diagnostic while awaiting
further medical investigation. However, future studies
with larger sample sizes are needed to confirm the cap-
acity of this test to distinguish neurogenic claudication
from vascular claudication.
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